Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient ; day:12 ; month:1 ; year:2021 ; pages:1-2
Annals of hematology ; (12.1.2021), 1-2
- Urheber
-
Schlaweck, Sebastian
Brossart, Peter
Heine, Annkristin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-021-04403-4
- URN
-
urn:nbn:de:101:1-2021030520502559541613
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schlaweck, Sebastian
- Brossart, Peter
- Heine, Annkristin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bloodless tandem autologous transplant in Jehovah’s Witness patients
A Jehovah's Witness Patient with Polytrauma: Deontology, Law, and Faith
Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
Skin changes in hairy cell leukemia
Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
Giant Coronary Aneurysm with Coronary-Pulmonary Artery Fistula in a Jehovah's Witness
Hairy cell leukemia expresses programmed death-1
Thirty years a Watch Tower slave : the confessions of a converted Jehovah's Witness
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year Experience
Hairy Cell Leukemia: Where Are We in 2023?
Targeting MEK in vemurafenib-resistant hairy cell leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Bloodless tandem autologous transplant in Jehovah’s Witness patients
A Jehovah's Witness Patient with Polytrauma: Deontology, Law, and Faith
Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
Skin changes in hairy cell leukemia
Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
Giant Coronary Aneurysm with Coronary-Pulmonary Artery Fistula in a Jehovah's Witness
Hairy cell leukemia expresses programmed death-1
Thirty years a Watch Tower slave : the confessions of a converted Jehovah's Witness
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year Experience
Hairy Cell Leukemia: Where Are We in 2023?
Targeting MEK in vemurafenib-resistant hairy cell leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Bloodless tandem autologous transplant in Jehovah’s Witness patients
A Jehovah's Witness Patient with Polytrauma: Deontology, Law, and Faith
Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
Skin changes in hairy cell leukemia
Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
Giant Coronary Aneurysm with Coronary-Pulmonary Artery Fistula in a Jehovah's Witness
Hairy cell leukemia expresses programmed death-1
Thirty years a Watch Tower slave : the confessions of a converted Jehovah's Witness
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year Experience
Hairy Cell Leukemia: Where Are We in 2023?
Targeting MEK in vemurafenib-resistant hairy cell leukemia